
December 21, 2022
The U.S. FDA has granted Emergency Use Authorization for CTK Biotech’s ImmuView® COVID-19 Antigen Home Test On December 20th, CTK Biotech obtained the FDA’s Emergency Use Authorization for their ImmuView® COVID-19 Antigen Home Test, a few months after being the first to receive the WHO...
Read More >July 19, 2022
On July 18th 2022, CTK Biotech’s OnSite® COVID-19 Ag Self Test received WHO Emergency Use Listing for meeting WHO’s quality, safety, and performance requirements. CTK’s COVID-19 Ag Self Test is the first in the market to receive this Pre-Qualification. This milestone accomplishment reflects CTK’s 20-plus...
Read More >CTK Biotech values knowledge, flexibility, and open communication to maintain the honest relationships within our team and our clients.
Whether you’re looking for answers or would like to solve a problem, we’ll help you resolve your issues quickly and easily.